BioPrax

BioPrax is a biotechnology company focused on developing innovative solutions to prevent and treat prosthetic joint infections (PJI). The company's core technology, the Lead-In system, is a localized drug delivery platform designed to be used during orthopedic surgeries to provide sustained release of antibiotics directly at the implant site. By targeting the biofilm that often forms on medical devices, BioPrax aims to significantly reduce the incidence of chronic infections and the need for revision surgeries. The company is currently advancing its lead programs through pre-clinical development with the goal of improving outcomes for patients undergoing joint replacements.